The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma
2021 · Scientific Reports · 15 citations
https://doi.org/10.1038/s41598-021-90381-6
M
Malin Nientiedt
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
306
Citations
10
h-index
11
i10-index
Malin Nientiedt is an academic researcher from Heidelberg University. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & RNA modifications and cancer & Urological Disorders and Treatments. The author has an h-index of 10, co-authored 27 publications.
ORCID: 0000-0001-7753-8982Papers by this author
worksLoss of YTHDC1 m6A reading function promotes invasiveness in urothelial carcinoma of the bladder
2025 · Experimental & Molecular Medicine · 5 citations
https://doi.org/10.1038/s12276-024-01377-x
Supplementary Material for: Prospective, Randomized Comparative Evaluation of a Novel Hands-On Endourology Training Curriculum
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21695225
Supplementary Material for: Upper Tract Urinary Cancer Recurrence after Radical Cystectomy: Risk Assessment of Intraoperative Frozen Section
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19121909
Supplementary Material for: Predicting Complexity in Transurethral Resection of Bladder Tumours: External Validation and Modification of the Bladder Complexity Score
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.22139861
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat